Learn More
Medchemexpress LLC Cintirorgon | 2055536-64-4 | MFCD31544352 | 99.1% | 603.53 g/mol | C27H23F6NO6S | 10 MG

Supplier: Medchemexpress LLC HY10403710MG
Cintirorgon is a selective, orally bioavailable agonist of the retinoic acid-related orphan receptor gamma (RORγ) developed for research in immuno-oncology. It modulates gene expression in RORγ-expressing T lymphocytes to enhance effector function, reduce immunosuppression, and has shown antitumor activity in preclinical studies.
- Selective RORγ agonist with targeted immunomodulatory activity.
- Orally bioavailable for in vivo pharmacology studies.
- Enhances T cell effector function and reduces immunosuppression.
- High supplied purity, supporting reliable experimental results.
- Characterized molecular profile for reproducible research use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.